Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin

World Journal of Gastroenterology

Volumn 13, Issue 34, 2007, Pages 4615-4619

  Diao, Yong ^a   Ma, Jian ^b   Xiao, Wei Dong ^c   Lu, Jia ^d   Li, Xin Yan ^a   Chu, Kin Wah ^b   Fung, Peter W C ^b   Habib, Nagy ^e   Farzaneh, Farzin ^f   Xu, Rui An ^a  

^a HUAQIAO UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adeno associated virus; Angiogenesis inhibitors; Colon; Kallistatin; Neoplasm

Indexed keywords

ANGIOGENESIS INHIBITOR; GREEN FLUORESCENT PROTEIN; KALLISTATIN; KI 67 ANTIGEN; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CELL PROLIFERATION; CELL STRAIN HCT116; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; VIRAL GENE THERAPY; VIRUS INFECTION;

EID: 34648834784     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i34.4615     Document Type: Article

References (18)

1. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342
2. Jain RK, Duda DG, Clark JW, Loeffler JS. Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol 2006; 3: 24-40
3. Kisker O, Becker CM, Prox D, Fannon M, D'Amato R, Flynn E, Fogler WE, Sim BK, Allred EN, Pirie-Shepherd SR, Folkman J. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res 2001; 61: 7669-7674
4. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3: 401-410
5. Folkman J, Kalluri R. Cancer without disease. Nature 2004; 427: 787
6. Miao RQ, Agata J, Chao L, Chao J. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood 2002; 100: 3245-3252
7. Li C, Bowles DE, van Dyke T, Samulski RJ. Adeno-associated virus vectors: potential applications for cancer gene therapy. Cancer Gene Ther 2005; 12: 913-925
8. Xu R, Sun X, Tse LY, Li H, Chan PC, Xu S, Xiao W, Kung HF, Krissansen GW, Fan ST. Long-term expression of angiostatin suppresses metastatic liver cancer in mice. Hepatology 2003; 37: 1451-1460
9. Sun X, Krissansen GW, Fung PW, Xu S, Shi J, Man K, Fan ST, Xu R. Anti-angiogenic therapy subsequent to adeno-associated-virus-mediated immunotherapy eradicates lymphomas that disseminate to the liver. Int J Cancer 2005; 113: 670-677
10. Xu R, Janson CG, Mastakov M, Lawlor P, Young D, Mouravlev A, Fitzsimons H, Choi KL, Ma H, Dragunow M, Leone P, Chen Q, Dicker B, During MJ. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther 2001; 8: 1323-1332
11. Shi J, Zheng D, Liu Y, Sham MH, Tam P, Farzaneh F, Xu R. Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice. Cancer Res 2005; 65: 1687-1692
12. Weidner N, Semple JP, Welch WR, Folkinan J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8
13. Sasaki T, Larsson H, Kreuger J, Salmivirta M, Claesson-Welsh L, Lindahl U, Hohenester E, Timpl R. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J 1999; 18: 6240-6248
14. Gallagher JT. Heparan sulfate: growth control with a restricted sequence menu. J Clin Invest 2001; 108: 357-361
15. Diao Y, Xu RA, Wang GJ, Zhao XC. Adeno-associated virus mediated expression of human erythropoietin in vitro. Acta Pharmacol Sin 2002; 23: 55-58
16. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002; 2: 727-739
17. Folkman J, Kalluri R. Cancer without disease. Nature 2004; 427: 787
18. Li C, Bowles DE, van Dyke T, Samulski RJ. Adeno-associated virus vectors: potential applications for cancer gene therapy. Cancer Gene Ther 2005; 12: 913-925